Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M192,574Revenue $M51,584Net Margin (%)42.7Z-Score2.6
Enterprise Value $M195,992EPS $3.2Operating Margin %30.5F-Score5
P/E(ttm))9.7Cash Flow Per Share $3.5Pre-tax Margin (%)30.5Higher ROA y-yY
Price/Book2.510-y EBITDA Growth Rate %3.2Quick Ratio2.1Cash flow > EarningsN
Price/Sales4.05-y EBITDA Growth Rate %8.5Current Ratio2.3Lower Leverage y-yY
Price/Cash Flow7.2y-y EBITDA Growth Rate %14.1ROA % (ttm)12.8Higher Current Ratio y-yN
Dividend Yield %3.3Insider Buy (3m)0ROE % (ttm)28.8Less Shares Outstanding y-yY
Payout Ratio %60.0Shares Outstanding M6,379ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 56.

PFE is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PFE John Hussman 2014-03-3117,00000.04New Buy
PFE Joel Greenblatt 2014-03-311,014,8080.020.49+356.54%
PFE David Dreman 2014-03-3111,85100.03+16.61%
PFE Ray Dalio 2014-03-31112,10800.03+1.54%
PFE Prem Watsa 2014-03-31235,00000.53
PFE Ruane Cunniff 2014-03-3111,02200
PFE Michael Price 2014-03-31347,1000.011.4
PFE Charles Brandes 2014-03-315,743,7110.092.3-0.41%
PFE Mario Gabelli 2014-03-311,165,5740.020.2-1.53%
PFE Dodge & Cox 2014-03-3164,121,0171.012.1-1.79%
PFE James Barrow 2014-03-3159,895,5710.942.8-2.55%
PFE John Keeley 2014-03-3195,89300.05-8.21%
PFE Ronald Muhlenkamp 2014-03-3141,16900.23-8.77%
PFE Jean-Marie Eveillard 2014-03-317,866,4730.120.67-22.77%
PFE Vanguard Health Care Fund 2014-03-317,276,6220.110.66-40.13%
Premium Most recent portfolio changes are included for Premium Members only!

PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
OLSON LAURIE JExecutive Vice President 2014-06-12Sell36,275$29.532.74view
Germano Geno JGroup President 2014-06-02Sell30,000$29.682.22view
YOUNG JOHN DGroup President 2014-03-17Sell9,000$31.38-3.31view
PFIZER INC10% Owner 2014-03-12Buy272,727$11175.82view
CANGIALOSI LORETTA VSr. Vice President, Controller 2014-03-04Sell102,943$32.05-5.34view
Dolsten MikaelPresident R&D 2014-03-04Sell35,789$32.58-6.88view
SUSMAN SALLYExecutive Vice President 2014-03-04Sell67,585$32.59-6.9view
PFIZER INC10% Owner 2014-02-04Buy227,261$8279.25view
DAMELIO FRANK AExecutive Vice President 2014-01-13Sell131,810$30.82-1.56view
DAMELIO FRANK AExecutive Vice President 2014-01-13Sell28,190$30.86-1.69view

Press Releases about PFE :

    Quarterly/Annual Reports about PFE:

      News about PFE:

      Articles On GuruFocus.com
      Dodge & Cox Second Quarter 2014 Commentary Jul 23 2014 
      Pfizer: A Fairly Valued Stock Jul 23 2014 
      Although This Hedge Fund Changed Stocks in Three of Them Bet More Jul 21 2014 
      Guru Favorites Top GuruFocus Dividend Growers of the Weeks Jul 01 2014 
      Can Pfizer Make Up Its Loss? May 09 2014 
      Auxier Asset Management's Auxier Report - First Quarter 2014 May 06 2014 
      Will Pfizer’s Q1 2014 Earnings Beat the Street on May 5, 2014? May 05 2014 
      Wrong Marketing Lesson by Big Pharma May 03 2014 
      Mario Gabelli on Bill Ackman, Valeant, AT&T, DirecTV and Pfizer May 02 2014 
      Pfizer and Lockheed Martin Top Dividend Growers of the Week Apr 28 2014 

      More From Other Websites
      Pfizer Ltd’s Profit from operations before other income, finance cost and tax for the Quarter... Jul 25 2014
      Bristol-Myers profit tops forecasts, helped by newer drugs Jul 24 2014
      Botox Maker’s Bosses Put Money Where Their Mouths Are Jul 24 2014
      Pfizer Needs to Do a Deal, Analyst Says Jul 24 2014
      Michigan governor's campaign met with ambivalence Jul 24 2014
      Did Pfizer Make A Horrible Business Deal? Jul 24 2014
      [video] Caterpillar CEO sees mining 'green shoots' Jul 24 2014
      [video] Eli Lilly looking for smaller acquisitions: CEO Jul 24 2014
      [video] Results hurt by patent expirations: Eli Lilly CEO Jul 24 2014
      More Questions Raised About Boehringer Ingelheim's Pradaxa Jul 23 2014
      [video] Faber Report: Puma Biotech surges Jul 23 2014
      Puma Biotech up more than 270% in one day Jul 23 2014
      Prempro Plaintiffs’ Lawyers Settle $62 Million Fee Fight Jul 23 2014
      [video] Don't Expect Tax Inversion Fever to Break Anytime Soon Jul 22 2014
      Top U.S. lawmaker wants corporate tax loophole 'plugged now' Jul 22 2014
      Top U.S. lawmaker wants corporate tax loophole 'plugged now' Jul 22 2014
      Top U.S. lawmaker wants corporate tax loophole 'plugged now' Jul 22 2014
      U.S. Senate panel to debate wave of corporate tax-avoidance deals Jul 21 2014
      [video] Obstacle races attract sponsors Jul 21 2014

      Add Notes, Comments or Ask Questions

      User Comments

      ReplySEENSCO - 1 month ago
      PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      Email Hide